Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Fredrik Liedberg, Johan Abrahamsson, Carina Bernardo, Mats Bläckberg, Anders Edsjö, Markus Heidenblad, Christer Larsson, Gottfrid Sjödahl & Pontus Eriksson. (2023) UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice – from biobank to RNA-sequencing in real time. Scandinavian Journal of Urology 57:1-6, pages 2-9.
Read now
Read now
Eugen Y. H. Wang, Nicklas Pihlström, Per-Uno Malmström & Truls Gårdmark. (2022) Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study. Scandinavian Journal of Urology 56:3, pages 221-226.
Read now
Read now
Liwei Zhao, Ji Sun, Kai Wang, Shengcheng Tai, Runmiao Hua, Yufu Yu, Yi Fan & Jiaguo Huang. (2021) Development of a New Recurrence-Free Survival Prediction Nomogram for Patients with Primary Non-Muscle-Invasive Bladder Cancer Based on Preoperative Controlling Nutritional Status Score. Cancer Management and Research 13, pages 6473-6487.
Read now
Read now
Marie Andersson, Marthe Berger, Karsten Zieger, Per-Uno Malmström & Mats Bläckberg. (2021) The diagnostic challenge of suspicious or positive malignant urine cytology findings when cystoscopy findings are normal: an outpatient blue-light flexible cystoscopy may solve the problem. Scandinavian Journal of Urology 55:4, pages 263-267.
Read now
Read now
Stefanie Korsgaard Körner, Thomas Dreyer, Erik Skaaheim Haug, Tomas Jerlström, Peter J. Boström, Sigurdur Gudjonsson & Jørgen Bjerggaard Jensen. (2021) Which data are available in central registries on bladder cancer patients in the five Nordic countries. Scandinavian Journal of Urology 55:2, pages 135-141.
Read now
Read now
Per-Uno Malmström. (2020) Cystoscopic surveillance of patients with non-muscle-invasive bladder cancer revisited. Scandinavian Journal of Urology 54:5, pages 364-366.
Read now
Read now
Marie Schmidt Erikson, Astrid Christine Petersen, Klaus Kaae Andersen, Frederik Krogsdal Jacobsen, Karin Mogensen & Gregers Gautier Hermann. (2020) Do repeated transurethral procedures under general anesthesia influence mortality in patients with non-invasive urothelial bladder cancer? A Danish national cohort study. Scandinavian Journal of Urology 54:4, pages 281-289.
Read now
Read now
Yuki Matsuoka, Rikiya Taoka, Zhang Xia, Mikio Sugimoto & Yoshiyuki Kakehi. (2020) Hyperthermic therapy using warm sterile water enhances cytocidal effects on bladder cancer cells. Scandinavian Journal of Urology 54:1, pages 65-69.
Read now
Read now
Staffan Jahnson, Truls Gårdmark, Abolfazl Hosseini, Tomas Jerlström, Fredrik Liedberg, Per-Uno Malmström, Johan Rosell, Amir Sherif, Viveka Ströck, Christel Häggström, Lars Holmberg & Firas Aljabery. (2019) Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe). Scandinavian Journal of Urology 53:4, pages 200-205.
Read now
Read now
Reza Zare, Magnus Grabe, Gregers G Hermann & Per-Uno Malmström. (2018) Can routine outpatient follow-up of patients with bladder cancer be improved? A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration. Research and Reports in Urology 10, pages 151-157.
Read now
Read now
Eero Kaasinen, Hans Wijkström, Erkki Rintala, Oddvar Mestad, Staffan Jahnson & Per-Uno Malmström. (2016) Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder. Scandinavian Journal of Urology 50:5, pages 360-368.
Read now
Read now
Articles from other publishers (15)
Caroline S.A. de Lima, M. Isabel Rial-Hermida, Lucas Freitas de Freitas, Ana F. Pereira-da-Mota, Maria Vivero-Lopez, Aryel Heitor Ferreira, Sławomir Kadłubowski, Gustavo H.C. Varca, Ademar B. Lugão & Carmen Alvarez-Lorenzo. (2023) Mucoadhesive gellan gum-based and carboxymethyl cellulose -based hydrogels containing gemcitabine and papain for bladder cancer treatment. International Journal of Biological Macromolecules 242, pages 124957.
Crossref
Crossref
Yan Zhang, Zuojun Wang, Xue Yang, Qingchun Zhao & Long He. (2022) The influence of serum sodium concentration on prognosis in patients with urothelial carcinoma treated by radical cystectomy. Medicine 101:52, pages e31973.
Crossref
Crossref
E. Novruzov, K. Dendl, H. Ndlovu, P. L. Choyke, M. Dabir, M. Beu, F. Novruzov, E. Mehdi, F. Guliyev, S. A. Koerber, I. Lawal, G. Niegisch, J. Debus, U. Haberkorn, M. Sathekge & F. L. Giesel. (2022) Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET/CT in Patients with Bladder Cancer. Molecular Imaging and Biology 24:4, pages 651-658.
Crossref
Crossref
Brian C. Allen, Aytekin Oto, Oguz Akin, Lauren F. Alexander, Adam T. Froemming, Pat F. Fulgham, David J. Halpern, Lori Mankowski Gettle, Jodi K. Maranchie, Bhavik N. Patel, Michael N. Patlas, Nicola Schieda, Abhishek Solanki, Ismail B. Turkbey, Aradhana M. Venkatesan, Don C. Yoo & Mark E. Lockhart. (2021) ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update. Journal of the American College of Radiology 18:5, pages S126-S138.
Crossref
Crossref
Pablo Iruzubieta, Tomás Castiella, Eva Monleón, Carmen Berga, Guillermo Muñoz & Concepción Junquera. (2021) Primary cilia presence and implications in bladder cancer progression and invasiveness. Histochemistry and Cell Biology 155:5, pages 547-560.
Crossref
Crossref
Yuki Matsuoka, Rikiya Taoka, Kana Kohashiguchi, Yoichiro Tohi, Yasuyuki Miyauchi, Takuma Kato, Hiroyuki Tsunemori, Nobufumi Ueda & Mikio Sugimoto. (2021) Efficacy and toxicity of intravesical Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer. Current Urology 15:1, pages 16-21.
Crossref
Crossref
Karl H. Tully, Marco Moschini, Friedrich-Carl E. von Rundstedt, Atiqullah Aziz, Luis A. Kluth, Andrea Necchi, Michael Rink, Kees Hendricksen, Paul Sargos, Malte W. Vetterlein, Roland Seiler, Cedric Poyet, Wojciech Krajewski, Harun Fajkovic, Shahrokh F. Shariat, Evanguelos Xylinas & Florian Roghmann. (2020) Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer – examining the utility of classifying Ta bladder cancer based on size. Urologic Oncology: Seminars and Original Investigations 38:11, pages 851.e19-851.e25.
Crossref
Crossref
Artur Mezheyeuski, Ulrika Segersten, Lina Wik Leiss, Per-Uno Malmström, Jiri Hatina, Arne Östman & Carina Strell. (2020) Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome. Scientific Reports 10:1.
Crossref
Crossref
Brian C. Allen, Aytekin Oto, Oguz Akin, Lauren F. Alexander, Jaron Chong, Adam T. Froemming, Pat F. Fulgham, Shane Lloyd, Jodi K. Maranchie, Rekha N. Mody, Bhavik N. Patel, Nicola Schieda, Ismail B. Turkbey, Neha Vapiwala, Aradhana M. Venkatesan, Carolyn L. Wang, Don C. Yoo & Mark E. Lockhart. (2019) ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer. Journal of the American College of Radiology 16:11, pages S417-S427.
Crossref
Crossref
Annemarie Uhlig, Arne Strauss, Ali Seif Amir Hosseini, Joachim Lotz, Lutz Trojan, Marianne Schmid & Johannes Uhlig. (2018) Gender-specific Differences in Recurrence of Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. European Urology Focus 4:6, pages 924-936.
Crossref
Crossref
Malgorzata Maj, Anna Kokocha, Anna Bajek & Tomasz Drewa. (2018) The interplay between adipose-derived stem cells and bladder cancer cells. Scientific Reports 8:1.
Crossref
Crossref
Tahlita C.M. Zuiverloon, Kim E.M. van Kessel, Trinity J. Bivalacqua, Joost L. Boormans, Thorsten H. Ecke, Petros D. Grivas, Anne E. Kiltie, Fredrik Liedberg, Andrea Necchi, Bas W. van Rhijn, Florian Roghmann, Marta Sanchez-Carbayo, Bernd J. Schmitz-Dräger, Felix Wezel & Ashish M. Kamat. (2018) Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network. Urologic Oncology: Seminars and Original Investigations 36:9, pages 423-431.
Crossref
Crossref
Kim E.M. van Kessel, Kirstin A. van der Keur, Lars Dyrskjøt, Ferran Algaba, Naeromy Y.C. Welvaart, Willemien Beukers, Ulrika Segersten, Bastian Keck, Tobias Maurer, Tatjana Simic, Marcus Horstmann, Marc-Oliver Grimm, Gregers G. Hermann, Karin Mogensen, Arndt Hartmann, Niels Harving, Astrid C. Petersen, Jørgen B. Jensen, Kerstin Junker, Joost L. Boormans, Francisco X. Real, Núria Malats, Per-Uno Malmström, Torben F. Ørntoft & Ellen C. Zwarthoff. (2018) Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups. Clinical Cancer Research 24:7, pages 1586-1593.
Crossref
Crossref
B. K. Andreassen, B. Aagnes, R. Gislefoss, M. Andreassen & R. Wahlqvist. (2016) Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014. BMC Cancer 16:1.
Crossref
Crossref
Fredrik Liedberg, Ulf Gerdtham, Katarina Gralén, Sigurdur Gudjonsson, Staffan Jahnson, Irene Johansson, Oskar Hagberg, Staffan Larsson, Anna-Karin Lind, Annica Löfgren, Jenny Wanegård, Hanna Åberg & Mef Nilbert. (2016) Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study. British Journal of Cancer 115:7, pages 770-775.
Crossref
Crossref